Elsevier launches COVID-19 Healthcare Hub

Free resource aims to help clinicians around the world in combatting the on-going pandemic


Philadelphia, April 16, 2020

Elsevier, a global leader in information analytics specializing in science and health, has launched a new resource to aid healthcare workers on the front lines of managing the novel coronavirus health crisis.

The COVID-19 Healthcare Hub provides free access to toolkits, expert insights, research resources and COVID-19 guidelines. The Hub’s toolkits include evidence-based clinical overviews, drug monographs, care plans, order sets, and procedure videos for clinicians delivering care and information to patients. Clinicians will also find the latest information and guidelines from government health agencies, medical societies and public health organizations for diagnosis, testing and treatment of COVID-19 patients.

“As clinicians manage high patient volumes, health systems and providers urgently need access to the latest evidence-based information,” said John Danaher, MD, President, Global Clinical Solutions, Elsevier. “The Healthcare Hub is a tool to support the medical community during this crisis.”

The COVID-19 Healthcare Hub’s mobile-friendly, responsive format allows clinicians to access the patient care information they need from their mobile phones, tablets or computers.

“We designed the Healthcare Hub to provide a seamless user experience that ensures vital content is accessible – wherever and whenever it is needed,” said Dr. Danaher.

Healthcare professionals can access Elsevier’s COVID-19 Healthcare Hub by visiting elsevier.health.

The COVID-19 Healthcare Hub is part of Elsevier’s contributions to help researchers and clinicians during this global crisis. Elsevier’s Novel Coronavirus Information Center provides the latest early stage and peer-reviewed research on the novel coronavirus and COVID-19. All resources are free to access and include guidelines for clinicians and patients. The Information Center links to the Coronavirus Hub on ScienceDirect, with more than 21,000 articles relevant to coronavirus, SARS and MERS freely available. For an expanding list of Elsevier contributions, see this directory.

---

About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com.

Media contact
Christopher Capot
Elsevier Communications, US
+1 917 704 5174
c.capot@elsevier.com